FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

James Rodgers

Research Profile

Chemicals & Drugs

Living Beings

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
Jeffrey W Corbett; James D Rodgers
Discovery of second generation quinazolinone non-nucleoside reverse transcriptase inhibitors of HIV-1.
Mona Patel; RJ McHugh; Beverly C Cordova; Ronald Klabe; Lee Bacheler; Susan Erickson-Viitanen; James D Rodgers
Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors.
AJ Cocuzza; DR Chidester; Beverly C Cordova; Ronald Klabe; S Jeffrey; Sharon Diamond; C A Weigelt; Soo S Ko; Lee Bacheler; Susan Erickson-Viitanen; James D Rodgers
4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of James Rodgers (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2002: Jeffrey W Corbett; James D Rodgers
Discovery of second generation quinazolinone non-nucleoside reverse transcriptase inhibitors of HIV-1.
Progress in medicinal chemistry 2002;40():63-105.
2001: Mona Patel; RJ McHugh; Beverly C Cordova; Ronald Klabe; Lee Bacheler; Susan Erickson-Viitanen; James D Rodgers
Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors.
Bioorganic & medicinal chemistry letters 2001;11(14):1943-5.
2001: AJ Cocuzza; DR Chidester; Beverly C Cordova; Ronald Klabe; S Jeffrey; Sharon Diamond; C A Weigelt; Soo S Ko; Lee Bacheler; Susan Erickson-Viitanen; James D Rodgers
4,1-Benzoxazepinone analogues of efavirenz (Sustiva) as HIV-1 reverse transcriptase inhibitors.
Bioorganic & medicinal chemistry letters 2001;11(11):1389-92.
2001: Jeffrey W Corbett; K J Kresge; S Pan; Beverly C Cordova; Ronald Klabe; James D Rodgers; Susan Erickson-Viitanen
Trifluoromethyl-containing 3-alkoxymethyl- and 3-aryloxymethyl-2-pyridinones are potent inhibitors of HIV-1 non-nucleoside reverse transcriptase.
Bioorganic & medicinal chemistry letters 2001;11(3):309-12.
2001: Jeffrey W Corbett; S Pan; Jay A Markwalder; Beverly C Cordova; Ronald Klabe; Sena Garber; James D Rodgers; Susan Erickson-Viitanen
3,3a-Dihydropyrano[4,3,2-de]quinazolin-2(1H)-ones are potent non-nucleoside reverse transcriptase inhibitors.
Bioorganic & medicinal chemistry letters 2001;11(2):211-4.
2000: Mona Patel; RJ McHugh; Beverly C Cordova; Ronald Klabe; Susan Erickson-Viitanen; George L Trainor; James D Rodgers
Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors.
Bioorganic & medicinal chemistry letters 2000;10(15):1729-31.
2000: Jeffrey W Corbett; Soo S Ko; James D Rodgers; L A Gearhart; N A Magnus; Lee Bacheler; Sharon Diamond; S Jeffrey; Ronald Klabe; Beverly C Cordova; Sena Garber; Kelly Logue; George L Trainor; PS Anderson; Susan Erickson-Viitanen
Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors.
Journal of medicinal chemistry 2000;43(10):2019-30.
2000: Jeffrey W Corbett; L A Gearhart; Soo S Ko; James D Rodgers; Beverly C Cordova; Ronald Klabe; Susan Erickson-Viitanen
Novel 2,2-dioxide-4,4-disubstituted-1,3-H-2,1,3-benzothiadiazines as non-nucleoside reverse transcriptase inhibitors.
Bioorganic & medicinal chemistry letters 2000;10(2):193-5.
1999: Jeffrey W Corbett; Soo S Ko; James D Rodgers; S Jeffrey; Lee Bacheler; Ronald Klabe; Sharon Diamond; C M Lai; S R Rabel; JA Saye; S P Adams; George L Trainor; PS Anderson; Susan Erickson-Viitanen
Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1.
Antimicrobial agents and chemotherapy 1999;43(12):2893-7.
1999: Mona Patel; James D Rodgers; RJ McHugh; BL Johnson; Beverly C Cordova; Ronald Klabe; Lee Bacheler; Susan Erickson-Viitanen; Soo S Ko
Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: novel biaryl indazoles as P2/P2' substituents.
Bioorganic & medicinal chemistry letters 1999;9(22):3217-20.
1998: James D Rodgers; Patrick Y S Lam; BL Johnson; H Wang; R Li; Y Ru; Soo S Ko; Steven P Seitz; George L Trainor; PS Anderson; Ronald Klabe; Lee Bacheler; Beverly C Cordova; Sena Garber; C Reid; Matthew R Wright; Chong-Hwan Chang; Susan Erickson-Viitanen
Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors.
Chemistry & biology 1998;5(10):597-608.
1998: James D Rodgers; BL Johnson; H Wang; Susan Erickson-Viitanen; Ronald Klabe; Lee Bacheler; Beverly C Cordova; Chong-Hwan Chang
Potent cyclic urea HIV protease inhibitors with 3-aminoindazole P2/P2' groups.
Bioorganic & medicinal chemistry letters 1998;8(7):715-20.